Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If their buildout goes as planned and they are able to fill it, I would say $40-45. If they are able to expand or there is a buyout, $50-60.
Good one.
I hope you're right, but that would be a buyout number in my opinion.
Classic
That stock brings back some bad memories for me. All the talk of buyouts and multi hundred dollar share price and manipulation alone keeping it down. I have PPHM PTSD. It is certainly no PPHM but I understand the theory behind the science but not the science.
I bought before the last runup at $15 and sold at $27, then bought back at $17 which I still have. I think until that EUA question gets answered one way or the other it may hang around between $16-$20, possibly a little higher as we get closer to the answer, 30 to 60 days from now. EUA will give it a big boost, 30's, no EUA would be bad. I know it has other indications and a good deal of money but this stock definitely does get played and yanked around.
That's a tough board over there. That 10Irishguy gets beat up pretty good whenever he gives his point of view. Personally I like seeing the other side if it's reasonable.
Agreed, and low volume.
Good news with HGEN could bump us up some prior to any cc.
Good advice. You should consider it. Spewing murder over a failed drug that never amounted to anything. Yes, I'm a fool. You're a funny guy.
Oh gosh, I had no idea that Dr. Thorpe was murdered for Bavi, the wonder drug. That is truly amazing. Thanks for the info. Chuckle.
That's what I took from it.
"time will tell if this was good or not for retail"
This really lines up with what you have posted recently.
Ok I guess we just we disagree on the financing. I like it, but it's still an incomplete until we find out what they do with that extra $75m or so after the fit-up and buying back the preferred. If they use it to buy a smaller company or more space and it tacks on an additional $5 - $10 to the pps in a few years, it was a great deal. We'll see.
Actually, using BR's methodology it would be a POS today. At one point today it was at $18.11 and now it's at $17.93. This POS is down! You have to pick a point where it was at an exact high, and if it is currently below that, the stock is a POS and the people running the company are garbage. It's kind of a tough game to win using those rules I agree.
I would agree, we should definitely use the last four weeks in making that call. That is for sure the best barometer. Don't go back 6 months or a year in making that comparison, that would be foolish. Make the call on the last four weeks.
Good one.
I don't consider myself a cheerleader of the old regime but I am perfectly happy with who is in charge now. A month ago we touched $22 pps. I didn't think we deserved to be there. What did Nick do in the past month to tank the stock price? He had an excellent conference call with increased revenue projections and record backlog. He explained that the two phases of the expansion were being accelerated and running simultaneously. Then he had the audacity to fund the buyout of the 10.5% preferred and pay for the expansion with cheap money leaving an excess of funds of about $75m or so. Previously he had said that they may look at small acquisitions. At the time, I was confused as to how. If that's the case or if they hope to use that money for further expansion, nothing is final yet. I don't feel the need for them to tell us every thought or wish for the company prior to it happening more than they already have.
If they had webcasted that conference and it was just a rehash of the conference call, which I'm sure it was, people would have complained that there was nothing new so why bother. There was no secret or inside information at that conference.
The share price is $16-$18 now which is fair. I expect it to be $30-$40 in the next three to five years if they execute decently and possibly more depending on what they do with the additional funds and hopefully profits.
I'm good with that.
So they may raise close to $140m at 1.25% with potential dilution of 4-5m shares down the road? My question is what they plan on doing with the $100m they have after they buy back the preferred and complete the fit-up that gets us to $270m capacity in a couple of years.
If you are waiting for Bavi to come through before you decide to sell any shares I hope you are very, very young.
Glad you're back. This is an important day. I was hoping somebody would come in and mention a bunch of random names and entities that have nothing to do with CDMO. Wolchock is a very important figure in the future success of CDMO, although he has done so much for us already.
After twenty years, hundreds of millions of dollars and a number of failed and stopped trials, how much do you think Bavi is worth to CDMO's share price now and in the future?
Thanks and keep up the wonderful sleuthing.
About the same. Still like where we are at.
Sign me up for a share of HALO for 1.5 shares of CDMO.
A. I believe that Dart sold out.
2. CDMO is years and years away from ever paying out dividends. Likely never.
Agree 100%. I still believe we will never see anything from Bavi or anything else we unloaded for $8m. The share price here seems to be way ahead of itself from what I can see, but I'll take it.
Got a little TRIL at about $11.
A question I've many times. When do you see these Oncxerna profits? Certainly not less than five years down the road.
2-4 years if ever.
I wouldn't have the guts to sell it all after all this time. 25% if it hits $20. I would buy back at $15-16 if it went back down. If not I'd live with it.
Love what's happening with this company and the stock price. It almost seems like the additional capacity is already priced in as if it was completed and rolling at 100%.
There has to be more to this move than any or all of the following -
Revenue projection bump on last cc. Good but not crazy big.
Beginning of expansion buildout - I think that was known to be coming.
Forty new ee's for vaccine that they will retain - maybe it's this one?
Zero.
Great, thanks. My bad. Bavi is awesome and you’re the best. Appreciate all of your valuable insight. You’re a real godsend. Spot on since day one.
Keytruda is not a failure. It passed multiple trials and generates revenue. Can you see the difference between that and what Bavi has done? It is a pretty important distinction.
I would love for Bavi to be worth something to the pps of CDMO. It isn’t. The pps is based entirely on the CDMO business. That is indisputable. There is a reason that management never discusses Bavi and analyst never ask about Bavi and it is not nefarious. Sorry.
Yes, you are correct. I am anticipating the continuation of no money from a drug that has been around for twenty years and has produced nothing. Quite a stretch on my part for sure.
Nothing screams success like investing hundreds of millions of dollars into a drug and then selling it for eight million dollars. A truly astounding success story.
Blaming somebody in Fargo ND for sabotaging a trial for no apparent gain to themselves for the benefit of God knows who is much easier than admitting Bavi was a dog being used as an ATM by a few crooks.
"How much is PS Targeting worth now ? “
To CDMO? $0
Yes, but I always kick myself for not having more. Tried to buy more the last time it touched seven but came up empty. Oh well. I probably have enough.
Should see some $15 to $18 estimates in the next few days I would think.
My legitimate response to this wouldn’t last thirty seconds so I’m not putting in the effort. I will say look at post history and accuracy. Try to find even a kernel of validation.
There is a very good reason why these posts don’t seem to relate to us or make any sense at all.
"Lots of no disclosures out there and unsealing of multiple lawsuits - even with Clinical Suppies Management CEO Gerald Finken and Jeanette Bleecker will lift this $9 stock to $50 overnight just for starters"
Sweet, $50 per share. You're the best! And so consistent!
Hey, for the record, what is 15% of $1b? I'm not good with numbers.
Thanks again and keep up the good work, you're doing wonders. I've always thought that the Jeanette Bleeker unraveling is what would get us to $50 per share and beyond. Nine years in the making. Really good stuff!
Who doesn't? He isn't.
Thanks for the response. I got your message and will definitely look into it. I wished I'd seen it months ago.
I am currently up some here, and if they can succeed with their business plan should do pretty well. I realize it will be complete luck. If I've learned anything here it's that people believe what they want to believe and decide to follow their own set of facts.
I have no idea how anyone could take the following set of facts and determine that Bavi is a billion dollar drug.
Been around for twenty years.
Earned zero dollars revenue.
Failed every important trial it was ever in.
Had hundreds of millions of dollars spent on it.
Sold for $8 million dollars to some start-up.
The sabotage theory doesn't hold any water either. Who sabotaged it and to what end? Some incompetent employee? Why? Who paid her? Makes no sense.
Any BP could have purchased Bavi for the equivalent of a rounding error or couch cushion change. They didn't.
Billion dollar drug? No chance.